Mydecine Innovations Group (TSE:MYCO)
CNQX:MYCO
Holding TSE:MYCO?
Track your performance easily

Mydecine Innovations Group (MYCO) Cash flow

94 Followers

Mydecine Innovations Group Cash Flow

TSE:MYCO's free cash flow for Q4 2023 was C$-9.75K. For the 2023 fiscal year, TSE:MYCO's free cash flow was decreased by C$4.21M and operating cash flow was C$-9.75K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
C$ 105.23KC$ -4.22MC$ -8.43MC$ -24.05MC$ -7.12MC$ -1.49M
Investing Cash Flow
C$ 25.20KC$ 525.20KC$ -37.54KC$ -473.58KC$ -573.42KC$ 4.44K
Financing Cash Flow
C$ -107.00KC$ 3.72MC$ 6.98MC$ 23.83MC$ 9.92MC$ 1.48M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 108.88KC$ 37.59KC$ 10.97KC$ 1.50MC$ 2.19MC$ 18.21K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----C$ 14.79K
Issuance Of Capital Stock
C$ -217.00KC$ 3.61MC$ 6.91MC$ 15.33MC$ 4.69MC$ 657.15K
Issuance Of Debt
C$ 110.00KC$ 110.00KC$ 73.14KC$ 5.50MC$ 4.60M-
Repayment Of Debt
--C$ -102.50KC$ -37.74KC$ -100.00K-
Free Cash Flow
C$ 105.23KC$ -4.22MC$ -8.43MC$ -24.34MC$ -7.12MC$ -1.49M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Mydecine Innovations Group Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis